Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEPress Release▲ PositiveResults19m ago

IndusInd Bank Limited

Press Release

IndusInd Bank Limited has announced its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, with net interest income at ₹4,685 crores, net profit at ₹1,037 crores, and a total capital adequacy ratio of 17.15%.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults20m ago

IndusInd Bank Limited

Investor Presentation

IndusInd Bank has released its Q1FY27 investor presentation, highlighting a 3% YoY growth in total deposits, 1% YoY growth in total loans, and a 72% YoY growth in net profit. The bank's retail deposit share increased to 49.5% from 47.9% QoQ, while wholesale loans grew 7% QoQ. Net interest margins (excluding one-offs) stood at 3.35% vs 3.46% YoY and 3.39% QoQ. The bank's asset quality continued to improve with lower slippages and NNPAs.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults21m ago

Indusind Bank Ltd

Press Release : Q1 FY 26-27

Indusind Bank Ltd has announced its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, with net interest income at ₹4,685 crores, net profit at ₹1,037 crores, and a net worth of ₹64,798 crores.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults23m ago

Indusind Bank Ltd

Please find attached Investor Presentation for quarter June 30, 2026

IndusInd Bank Ltd has released its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026, showing a 1% YoY increase in net interest income and an 8% YoY growth in operating profit. The bank's net profit grew 72% YoY and 75% QoQ to ₹1,037crs. The bank's asset quality continued to improve with GNPA at 3.25% and NPA at 0.95%. The bank's CRAR stood at 17.15% and PCR at 71%. The bank's key financial metrics showed a 3% YoY increase in loans and a 4% QoQ increase in deposits.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults24m ago

Jio Financial Services Ltd

Transcript of Presentation on the unaudited financial results (Consolidated and Standalone) for the quarter ended June 30, 2026

Jio Financial Services Ltd reported strong Q1 FY27 earnings, with Consolidated Total Income growing 141% YoY to ₹1,496 crores, and Profit Before Tax excluding dividend and exceptional item expanding 18% YoY to ₹461 crores. The company's lending business, Jio Credit, saw its Gross AUM surge 2.6x year-on-year to ₹30,667 crores, while Jio Payments Bank deposits grew 1.7x to ₹617 crores. The company's insurance premiums facilitated reached ₹238 crores, and JioBlackRock AMC scaled its closing AUM to ₹18,412 crores.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults26m ago

Dr Reddys Laboratories Ltd

Outcome of Board Meeting held on July 22, 2026

Dr Reddy's Laboratories Ltd announced unaudited financial results for the quarter ended June 30, 2026, with revenues of Rs 80,705 million, gross profit of Rs 37,540 million, and profit for the period of Rs 4,348 million. The company also announced the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, and the appointment of M/s Deloitte Haskins & Sells, LLP as Independent Registered Public Accounting Firm.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults33m ago

Piramal Finance Ltd

Transcript of conference call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026

Piramal Finance Ltd reported Q1 FY2027 earnings, with growth AUM increasing by 32% YoY and total AUM growing by 25% YoY to Rs. 1,06,940 crores. PAT was up 67% YoY to Rs. 461 crores, with underlying Growth business PBT of Rs. 470 crores. The company approved a fund-raise of up to Rs. 4,000 crores.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults33m ago

Piramal Finance Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Piramal Finance Limited reported Q1 FY27 results, with AUM growth of 25% YoY to Rs. 1,06,940 crores, and growth business profits driving PAT up 67% YoY to Rs. 461 crores. The company also announced a fund-raise of up to Rs. 4,000 crores, and received ratings of BBB / Stable from two Japanese credit agencies.

Read more →📎 1 attachment
BSECompany Update▲ PositiveOrder Win40m ago

Azad Engineering Ltd

We wish to inform that Azad delivered its first Expendable Indigenous Turbo Jet Engine to DRDO (Defence Research and Development Organisation) and the Ministry of Defence , Government of ....

Azad Engineering Ltd has delivered its first Expendable Indigenous Turbo Jet Engine to DRDO and the Ministry of Defence, marking a significant milestone in India's journey towards self-reliance in the aerospace and defence sector.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion40m ago

EBIX Ltd

Media Release titled "EBIX LIMITED WELCOMES RBI''S LANDMARK APPROVAL EXPANDING EBIXCASH WORLD MONEY''S TRADE REMITTANCE CAPABILITIES- EbixCash World Money becomes India''s first non-bank ....

Ebix Limited's subsidiary, EbixCash World Money, has received RBI approval to undertake trade remittances, becoming the first non-bank institution in India to receive such approval, expanding its perpetual Authorised Dealer Category-II (AD-II) license.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults47m ago

IIFL Finance Limited

Press Release

IIFL Finance Limited announced its Q1FY27 financial results, delivering strong growth, improved asset quality, and robust profitability. Total income for Q1FY27 stood at ₹2,202.4 Cr, up 34% YoY, while pre-provision operating profit rose 50% YoY to ₹1,252.4 Cr. Profit before tax increased 161% YoY to ₹928.6 Cr, and PAT (pre-NCI) stood at ₹713.1 Cr, marking a 160% YoY growth.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults47m ago

IIFL Finance Limited

Investor Presentation

IIFL Finance Limited has announced its financial results for the quarter ended June 30, 2026, with a PAT of ₹713.1 Cr, up 14% QoQ and 160% YoY. The company's AUM grew to ₹1,15,523 Cr, up 7% QoQ and 38% YoY. The company has also raised US$500 mn through Social Bonds Issuance proceeds and has been assigned a Ba3 Issuer rating by Moody's.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults48m ago

IIFL Finance Ltd

IIFL Finance Limited has informed the Exchanges regarding Q1FY27 Results Press Release.

IIFL Finance Ltd announced its Q1FY27 results, delivering strong growth, improved asset quality, and robust profitability. Total income stood at ₹2,202.4 Cr, up 34% YoY, while pre-provision operating profit rose 50% YoY to ₹1,252.4 Cr. Profit before tax increased 161% YoY to ₹928.6 Cr, reflecting strong operating leverage and improved asset quality. PAT (pre-NCI) stood at ₹713.1 Cr, marking a 160% YoY growth.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveOrder Win50m ago

Azad Engineering Limited

General Updates

Azad Engineering Limited has delivered its first expendable indigenous turbo jet engine to DRDO and the Ministry of Defence, marking a significant milestone in India's journey towards self-reliance in propulsion. This achievement highlights Azad's expertise in precision manufacturing, advanced engineering, and complex Aero-engine systems.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion1h ago

Rubicon Research Ltd

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 (''SEBI Listing Regulations'') - Acquisition of a Manufacturing Facility in USA.

Rubicon Research Ltd, a pharmaceutical company, has acquired a manufacturing facility in East Brunswick, New Jersey, USA from InvaTech Pharma Solutions, LLC for an enterprise value of USD 2.9 million. The facility will focus on Rubicon's specialty and high-value products as well as demand from US government departments. Manufacturing is expected to commence in calendar year 2027.

Read more →📎 1 attachment
NSEPress Release▲ PositiveExpansion1h ago

Rubicon Research Limited

Press Release

Rubicon Research Limited has acquired a manufacturing facility in East Brunswick, New Jersey, USA from InvaTech Pharma Solutions, LLC for USD 2.9 million. The facility will focus on Rubicon's specialty and high-value products as well as demand from US government departments. The company expects to commence manufacturing at the site in calendar year 2027 after completing implementation of its quality management systems.

Read more →📎 1 attachment
BSEOthers▲ PositiveResults1h ago

Century Extrusions Ltd

Regulations 30 and 34 - Electronic copy of the Notice of the 38th Annual General Meeting and Annual Report of the Company for the financial year 2025-2026.

Century Extrusions Limited, an agile and fast-growing aluminium extrusion company, has emerged as a reliable provider of end-to-end extrusion-based components for infrastructure, electrical, industrial, and mobility applications across India. With decades of experience in precision aluminium profiles and customized engineering solutions, the company has consistently scaled its revenue base while strengthening operational discipline.

Read more →📎 1 attachment
Page 1 of 87Next →